Ignite Creation Date:
2024-05-05 @ 11:50 PM
Last Modification Date:
2024-10-26 @ 10:40 AM
Study NCT ID:
NCT01435031
Status:
COMPLETED
Last Update Posted:
2018-05-09
First Post:
2011-09-13
Brief Title:
EXPERT CTO Evaluation of the XIENCE PRIME LL and XIENCE Nano Everolimus Eluting Coronary Stent Coronary Stents Performance and Technique in Chronic Total Occlusions
Sponsor:
Abbott Medical Devices
Organization:
Abbott Medical Devices
Study Overview
Official Title:
Evaluation of the XIENCE PRIME LL and XIENCE Nano Everolimus Eluting Coronary Stent Coronary Stents Performance and Technique in Chronic Total Occlusions
Status:
COMPLETED
Status Verified Date:
2018-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EXPERT CTO
Brief Summary:
A prospective multi-center single-arm study to establish the safety and effectiveness of the XIENCE V Everolimus Eluting Coronary Stent XIENCE nano Everolimus Eluting Coronary Stent XIENCE PRIME LL Everolimus Eluting Coronary Stent HT PROGRESS and HT PILOT Coronary Guide Wires and MINI-TREK Coronary Dilatation Catheter in patients undergoing elective percutaneous revascularization of native chronic total coronary occlusions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None